PL3854784T3 - Sposób wytwarzania pochodnej 4‑metoksypirolu - Google Patents
Sposób wytwarzania pochodnej 4‑metoksypiroluInfo
- Publication number
- PL3854784T3 PL3854784T3 PL19863941.1T PL19863941T PL3854784T3 PL 3854784 T3 PL3854784 T3 PL 3854784T3 PL 19863941 T PL19863941 T PL 19863941T PL 3854784 T3 PL3854784 T3 PL 3854784T3
- Authority
- PL
- Poland
- Prior art keywords
- producing
- pyrrole derivative
- methoxy pyrrole
- methoxy
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/48—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20180112196 | 2018-09-19 | ||
| KR1020190110997A KR102126576B1 (ko) | 2018-09-19 | 2019-09-06 | 4-메톡시 피롤 유도체의 제조 방법 |
| PCT/KR2019/012122 WO2020060213A1 (ko) | 2018-09-19 | 2019-09-19 | 4-메톡시 피롤 유도체의 제조 방법 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3854784T3 true PL3854784T3 (pl) | 2026-07-06 |
Family
ID=69959291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19863941.1T PL3854784T3 (pl) | 2018-09-19 | 2019-09-19 | Sposób wytwarzania pochodnej 4‑metoksypirolu |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US12110271B2 (pl) |
| EP (1) | EP3854784B1 (pl) |
| JP (1) | JP7253624B2 (pl) |
| KR (1) | KR102126576B1 (pl) |
| CN (1) | CN112739684B (pl) |
| AU (1) | AU2019343857B2 (pl) |
| BR (1) | BR112021005156A2 (pl) |
| CL (1) | CL2021000639A1 (pl) |
| CO (1) | CO2021003195A2 (pl) |
| DO (1) | DOP2021000042A (pl) |
| EC (1) | ECSP21019076A (pl) |
| ES (1) | ES3074902T3 (pl) |
| FI (1) | FI3854784T3 (pl) |
| JO (1) | JOP20210040A1 (pl) |
| MA (1) | MA53673A (pl) |
| MX (1) | MX2021003137A (pl) |
| MY (1) | MY205351A (pl) |
| PE (1) | PE20211736A1 (pl) |
| PH (1) | PH12021550523A1 (pl) |
| PL (1) | PL3854784T3 (pl) |
| PT (1) | PT3854784T (pl) |
| RU (1) | RU2763287C1 (pl) |
| SA (1) | SA521421372B1 (pl) |
| SG (1) | SG11202101919VA (pl) |
| TN (1) | TN2021000035A1 (pl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102081920B1 (ko) | 2016-03-25 | 2020-02-26 | 주식회사 대웅제약 | 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민 염의 신규한 결정형 |
| KR102233455B1 (ko) * | 2017-06-21 | 2021-03-29 | 주식회사 대웅제약 | 4-메톡시피롤 유도체의 중간체 제조 방법 |
| KR102126576B1 (ko) | 2018-09-19 | 2020-06-24 | 주식회사 대웅제약 | 4-메톡시 피롤 유도체의 제조 방법 |
| UA130030C2 (uk) | 2020-12-18 | 2025-10-15 | Тевун Фармасутікал Ко., Лтд. | Препарат для перорального введення, який містить 1-(5-(2,4-дифлуорфеніл)-1-((3-флуорфеніл)сульфоніл)-4-метокси-1h-пірол-3-іл)-n-метилметанамін |
| AU2022280595B2 (en) | 2021-05-26 | 2024-11-14 | Daewoong Pharmaceutical Co., Ltd. | Medicine container comprising liquid pharmaceutical composition of 1-(5-(2,4-difluorophenyl)-1-((3- fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n-methylmethanamine |
| KR102556500B1 (ko) * | 2021-11-19 | 2023-07-19 | 하나제약 주식회사 | 피롤 유도체 또는 이의 약학적 또는 식품학적으로 허용 가능한 염, 및 이를 유효성분으로 포함하는 위장 질환의 예방, 개선 또는 치료용 조성물 |
| TW202411216A (zh) * | 2022-05-23 | 2024-03-16 | 南韓商日東製藥股份有限公司 | ６－甲氧基吡啶－３－基衍生物之製造方法 |
| KR102975773B1 (ko) * | 2022-05-23 | 2026-06-10 | 일동제약(주) | 6-메톡시피리딘-3-일 유도체의 제조방법 |
| CN117820193A (zh) * | 2022-09-29 | 2024-04-05 | 安徽皓元药业有限公司 | 一种非苏拉赞盐酸盐晶型a及其制备方法 |
| KR102938657B1 (ko) * | 2023-02-15 | 2026-03-12 | 주식회사 대웅제약 | 4-메톡시 피롤 유도체의 제조 방법 |
| WO2025023734A1 (en) * | 2023-07-26 | 2025-01-30 | Yunovia Co., Ltd. | Method for preparing intermediates of 6-methoxypyridine-3-yl derivatives |
| CN119462472A (zh) * | 2024-04-12 | 2025-02-18 | 菏泽皓元医药科技有限公司 | 一种钾离子竞争性阻滞剂中间体及其制备方法 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1592996A (en) | 1977-10-10 | 1981-07-15 | Rolland Sa A | Acylated pyrrole carboxylic acids and derivatives thereof |
| SI1397364T1 (sl) | 2001-05-24 | 2007-12-31 | Lilly Co Eli | Novi pirolni derivati kot farmacevtske uäśinkovine |
| MXPA05003022A (es) | 2002-09-20 | 2005-05-27 | Lupin Ltd | Nuevos compuestos antimicobacterianos. |
| JP5173192B2 (ja) * | 2004-09-30 | 2013-03-27 | 武田薬品工業株式会社 | プロトンポンプ阻害薬 |
| KR101115857B1 (ko) | 2005-08-30 | 2012-04-12 | 다케다 야쿠힌 고교 가부시키가이샤 | 산 분비 억제제로서 1-헤테로시클릴술포닐, 2-아미노메틸,5-(헤테로-) 아릴 치환된 1-ｈ-피롤 유도체 |
| US7994205B2 (en) | 2006-03-31 | 2011-08-09 | Takeda Pharmaceutical Company Limited | Aryl-or heteroaryl-sulfonyl compounds as acid secretion inhibitors |
| MX2008016338A (es) | 2006-06-27 | 2009-01-16 | Abbott Lab | Derivados de pirrol y sus metodos de uso. |
| US8933105B2 (en) * | 2007-02-28 | 2015-01-13 | Takeda Pharmaceutical Company Limited | Pyrrole compounds |
| US20110059940A1 (en) | 2008-05-08 | 2011-03-10 | Bristol- Myers Squibb Company | 2-Aryl Glycinamide Derivatives |
| CN104784180A (zh) | 2008-07-28 | 2015-07-22 | 武田药品工业株式会社 | 药物组合物 |
| NZ591793A (en) | 2008-08-27 | 2012-11-30 | Takeda Pharmaceutical | Substituted 1-(4-fluoro-5-(2-fluoropyridin-3-yl)-1-((pyrindin-2-yl)sulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine compounds |
| US8895558B2 (en) | 2008-10-02 | 2014-11-25 | Green Cross Corporation | Arylpiperazine-containing pyrrole 3-carboxamide derivatives for treating depressive disorders |
| GB0823003D0 (en) | 2008-12-17 | 2009-01-28 | Syngenta Participations Ag | Pyrrole derivatives with plant growth regulating properties |
| JP6292736B2 (ja) * | 2012-11-19 | 2018-03-14 | ジエンス ハンセン ファーマセウティカル カンパニー リミテッド | ピロールスルホンアミド誘導体、その製造法およびその医療用途 |
| KR102234597B1 (ko) | 2013-04-10 | 2021-03-31 | 다이이찌 산쿄 가부시키가이샤 | 피롤 유도체의 결정 및 그 제조 방법 |
| JP2017071553A (ja) | 2014-02-25 | 2017-04-13 | 味の素株式会社 | ヘテロ原子−メチレン−ヘテロ環構造を有する新規化合物 |
| CN104447491B (zh) | 2014-11-19 | 2017-06-23 | 连云港恒运医药有限公司 | 含吡咯环质子泵抑制剂的半富马酸盐及其中间体和医药用途 |
| KR101613245B1 (ko) * | 2015-04-27 | 2016-04-18 | 주식회사 대웅제약 | 신규의 4-메톡시 피롤 유도체 또는 이의 염 및 이를 포함하는 약학 조성물 |
| CN106432191A (zh) * | 2015-08-10 | 2017-02-22 | 陕西合成药业股份有限公司 | 一种新的吡咯类衍生物、其制备方法及其在医药上的应用 |
| KR102081920B1 (ko) | 2016-03-25 | 2020-02-26 | 주식회사 대웅제약 | 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민 염의 신규한 결정형 |
| KR20170113040A (ko) | 2016-03-25 | 2017-10-12 | 주식회사 대웅제약 | 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민의 신규한 산부가염 |
| WO2017164575A1 (en) | 2016-03-25 | 2017-09-28 | Daewoong Pharmaceutical Co.,Ltd. | Novel acid addition salt of 1-(5-(2,4-difluorophenyl)-1-((3- fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n- methylmethanamine |
| CN107879964B (zh) * | 2016-09-29 | 2023-02-10 | 江苏柯菲平医药股份有限公司 | 1-(5-(2-氟苯基)-1-(3-(3-甲氧丙氧基)苯磺酰氯)-1h-吡咯-3-基)-n-甲基胺的制备方法 |
| KR102233456B1 (ko) | 2017-05-31 | 2021-03-29 | 주식회사 대웅제약 | 4-메톡시피롤 유도체의 중간체 제조 방법 |
| KR102233455B1 (ko) | 2017-06-21 | 2021-03-29 | 주식회사 대웅제약 | 4-메톡시피롤 유도체의 중간체 제조 방법 |
| CN108503621B (zh) * | 2017-12-25 | 2021-09-14 | 上海中拓医药科技有限公司 | 一种富马酸沃诺拉赞的制备方法 |
| KR102126576B1 (ko) | 2018-09-19 | 2020-06-24 | 주식회사 대웅제약 | 4-메톡시 피롤 유도체의 제조 방법 |
| WO2020060213A1 (ko) | 2018-09-19 | 2020-03-26 | 주식회사 대웅제약 | 4-메톡시 피롤 유도체의 제조 방법 |
| AU2022280595B2 (en) | 2021-05-26 | 2024-11-14 | Daewoong Pharmaceutical Co., Ltd. | Medicine container comprising liquid pharmaceutical composition of 1-(5-(2,4-difluorophenyl)-1-((3- fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n-methylmethanamine |
-
2019
- 2019-09-06 KR KR1020190110997A patent/KR102126576B1/ko active Active
- 2019-09-19 CN CN201980061365.6A patent/CN112739684B/zh active Active
- 2019-09-19 JO JOP/2021/0040A patent/JOP20210040A1/ar unknown
- 2019-09-19 AU AU2019343857A patent/AU2019343857B2/en active Active
- 2019-09-19 MX MX2021003137A patent/MX2021003137A/es unknown
- 2019-09-19 FI FIEP19863941.1T patent/FI3854784T3/fi active
- 2019-09-19 US US17/273,390 patent/US12110271B2/en active Active
- 2019-09-19 PT PT198639411T patent/PT3854784T/pt unknown
- 2019-09-19 PE PE2021000303A patent/PE20211736A1/es unknown
- 2019-09-19 PL PL19863941.1T patent/PL3854784T3/pl unknown
- 2019-09-19 SG SG11202101919VA patent/SG11202101919VA/en unknown
- 2019-09-19 JP JP2021539323A patent/JP7253624B2/ja active Active
- 2019-09-19 RU RU2021110665A patent/RU2763287C1/ru active
- 2019-09-19 ES ES19863941T patent/ES3074902T3/es active Active
- 2019-09-19 BR BR112021005156-2A patent/BR112021005156A2/pt unknown
- 2019-09-19 MY MYPI2021001192A patent/MY205351A/en unknown
- 2019-09-19 TN TNP/2021/000035A patent/TN2021000035A1/en unknown
- 2019-09-19 MA MA053673A patent/MA53673A/fr unknown
- 2019-09-19 EP EP19863941.1A patent/EP3854784B1/en active Active
-
2021
- 2021-03-02 SA SA521421372A patent/SA521421372B1/ar unknown
- 2021-03-10 DO DO2021000042A patent/DOP2021000042A/es unknown
- 2021-03-10 PH PH12021550523A patent/PH12021550523A1/en unknown
- 2021-03-11 CO CONC2021/0003195A patent/CO2021003195A2/es unknown
- 2021-03-16 CL CL2021000639A patent/CL2021000639A1/es unknown
- 2021-03-18 EC ECSENADI202119076A patent/ECSP21019076A/es unknown